Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
151.7 USD | -0.90% |
|
-3.97% | +57.35% |
26/06 | Monetary policy is getting even more confusing | ![]() |
26/06 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.35% | 1.43TCr | |
+16.61% | 12TCr | |
+17.75% | 11TCr | |
+17.23% | 2.59TCr | |
-24.11% | 1.93TCr | |
-18.56% | 1.62TCr | |
-18.47% | 1.56TCr | |
-47.75% | 1.46TCr | |
+5.62% | 1.4TCr | |
+125.88% | 1.13TCr |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Transcript : Sarepta Therapeutics, Inc. Presents at Bank of America Napa Healthcare Conference, Jun-24-2020 09